Lofexidine for Opiate Withdrawal - 1
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 1/13/2017 |
| Start Date: | April 2001 |
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
The purpose of this study is to evaluate lofexidine for opiate withdrawal.
An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment
seeking individuals randomized to 2 medication groups: lofexidine and placebo to be
conducted in inpatient units at 3 treatment sites.
seeking individuals randomized to 2 medication groups: lofexidine and placebo to be
conducted in inpatient units at 3 treatment sites.
Inclusion Criteria:
Male or female as least 18 yrs of age & above with a current dependence on heroin,
morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent
and signed informed consent; females using appropriate birth control method.
Exclusion Criteria:
Additional criteria available during screening at the site
We found this trial at
3
sites
UCLA Medical Center Founded in 1955, UCLA Medical Center became Ronald Reagan UCLA Medical Center...
Click here to add this to my saved trials
Columbia University In 1897, the university moved from Forty-ninth Street and Madison Avenue, where it...
Click here to add this to my saved trials
Click here to add this to my saved trials